Literature DB >> 17877314

Fetal death certificates as a source of surveillance data for stillbirths with birth defects.

C Wes Duke1, C J Alverson, Anolfo Correa.   

Abstract

OBJECTIVE: We assessed fetal death certificates (FDCs) as a source of surveillance for stillbirths with birth defects by linkage with data from the Metropolitan Atlanta Congenital Defects Program (MACDP), a population-based birth defects surveillance system.
METHODS: Stillbirths with defects in MACDP were identified from 1994 through 2002 and linked to FDCs. Sensitivity of FDCs for capturing stillbirths with defects was estimated, and predictors for a case being reported were assessed. Concordance for selected variables from each data source was evaluated. RESILTS: Two hundred twenty-four of 257 stillbirths with birth defects in MACDP were linked to an FDC (linkage rate = 87.2%; 95% confidence interval [CI] 82.4, 91.0). Stillbirths of non-Hispanic black and Hispanic/other mothers were more likely to be issued an FDC (odds ratio [OR] = 5.6 [95% CI 1.9, 17.0] and 14.0 [95% CI 1.7, 114.0], respectively). Cases undergoing autopsy were more likely to be issued an FDC (OR = 3.2; 95% CI 1.1, 8.7). Performance of an amniocentesis was poorly recorded on FDCs. The sensitivity and positive predictive value of FDCs for selected classes of defects ranged from 10% to 70% and 25% to 93%, respectively.
CONCLUSIONS: Compared to FDCs, MACDP's active case identification improves the ascertainment of stillbirths with birth defects and the quality of certain recorded data.

Entities:  

Mesh:

Year:  2007        PMID: 17877314      PMCID: PMC1936952          DOI: 10.1177/003335490712200514

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  19 in total

1.  Birth defects surveillance: assessing the "gold standard".

Authors:  M A Honein; L J Paulozzi
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  Validity of maternal and perinatal risk factors reported on fetal death certificates.

Authors:  Mona T Lydon-Rochelle; Vicky Cárdenas; Jennifer L Nelson; Kay M Tomashek; Beth A Mueller; Thomas R Easterling
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

3.  Fetal deaths in the United States, 1997 vs 1991.

Authors:  Hongbo Yuan; Robert W Platt; Lucie Morin; K S Joseph; Michael S Kramer
Journal:  Am J Obstet Gynecol       Date:  2005-08       Impact factor: 8.661

4.  Fetal death ratios in a prospective study compared to state fetal death certificate reporting.

Authors:  M K Goldhaber
Journal:  Am J Public Health       Date:  1989-09       Impact factor: 9.308

5.  The surveillance of birth defects: the usefulness of the revised US standard birth certificate.

Authors:  M L Watkins; L Edmonds; A McClearn; L Mullins; J Mulinare; M Khoury
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  Accuracy of fetal death reports: comparison with data from an independent stillbirth assessment program.

Authors:  A E Greb; R M Pauli; R S Kirby
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

Review 7.  Wisconsin Stillbirth Service Program: I. Establishment and assessment of a community-based program for etiologic investigation of intrauterine deaths.

Authors:  R M Pauli; C A Reiser; R M Lebovitz; S J Kirkpatrick
Journal:  Am J Med Genet       Date:  1994-04-01

Review 8.  Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals.

Authors:  R M Pauli; C A Reiser
Journal:  Am J Med Genet       Date:  1994-04-01

9.  The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.

Authors:  Adolfo Correa-Villaseñor; Janet Cragan; James Kucik; Leslie O'Leary; Csaba Siffel; Laura Williams
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-09

10.  Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta.

Authors:  Csaba Siffel; Adolfo Correa; Janet Cragan; C J Alverson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2004-09
View more
  7 in total

1.  Evaluation of an active surveillance system for stillbirths in metropolitan Atlanta.

Authors:  Alejandro Azofeifa; Lorraine F Yeung; C Wes Duke; Suzanne M Gilboa; Adolfo Correa
Journal:  J Registry Manag       Date:  2012

2.  Fetal death certificate data quality: a tale of two U.S. counties.

Authors:  Lauren Christiansen-Lindquist; Robert M Silver; Corette B Parker; Donald J Dudley; Matthew A Koch; Uma M Reddy; George R Saade; Robert L Goldenberg; Carol J R Hogue
Journal:  Ann Epidemiol       Date:  2017-07-20       Impact factor: 3.797

3.  Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.

Authors:  Eric N Ouattara; Xavier Anglaret; Angela Y Wong; Jennifer Chu; Heather E Hsu; Christine Danel; Serge Eholié; Raoul Moh; Delphine Gabillard; Rochelle P Walensky; Kenneth A Freedberg
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

4.  Use of active surveillance methodologies to examine over-reporting of stillbirths on fetal death certificates.

Authors:  Jennifer A Makelarski; Paul A Romitti; Kristin M Caspers; Soman Puzhankara; Bradley D McDowell; Kimberly N Piper
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-09-30

5.  Challenges and priorities for surveillance of stillbirths: a report on two workshops.

Authors:  C Wes Duke; Adolfo Correa; Paul A Romitti; Joyce Martin; Russell S Kirby
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

6.  Using an existing birth defects surveillance program to enhance surveillance data on stillbirths.

Authors:  Wes Duke; Suzanne M Gilboa
Journal:  J Registry Manag       Date:  2014

7.  Design and Methodology of the Study of Associated Risks of Stillbirth (SOARS) in Utah.

Authors:  Carla L DeSisto; Nicole Stone; Barbara Algarin; Laurie Baksh; Ada Dieke; Denise V D'Angelo; Leslie Harrison; Lee Warner; Holly B Shulman
Journal:  Public Health Rep       Date:  2021-03-05       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.